Pharmacology

Action Mechanism of Action Reference
AGONIST Interferon alpha/beta receptor agonist FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Multiple Sclerosis 4 D009103 ClinicalTrials
Multiple Sclerosis, Relapsing-Remitting 3 D020529 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Renal Insufficiency 1 D051437 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
21.71
Nervous system disorders
14.25
Injury, poisoning and procedural complications
10.9
Skin and subcutaneous tissue disorders
8.47
Musculoskeletal and connective tissue disorders
7.14
Psychiatric disorders
5.81
Vascular disorders
4.34
Gastrointestinal disorders
3.57
Respiratory, thoracic and mediastinal disorders
3.23
Infections and infestations
3.1
Investigations
2.75
Immune system disorders
2.49
Cardiac disorders
2.42

Cross References

Resources Reference
CAS NUMBER 1211327-92-2
ChEMBL CHEMBL2108677
FDA SRS I8309403R0
Guide to Pharmacology 7637